Studies have suggested that increased serum IFN-α bioactivity and polymorphism of interferon regulatory factor 5 gene, a transcription factor essential for IFN-α secretion, are associated with SLE and lupus nephritis susceptibility, respectively [77, 78]. This evidence concerns the gene IFNA1 and lupus nephritis.